VanEck Vectors Biotech ETF news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

BBH 106.82 -0.69 (-0.64%)
price chart
The Zacks Analyst Blog Highlights: iShares Gold ETF, VanEck Vectors Coal ETF ...
Chicago, IL - September 26, 2016 - announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
Clinton Apparently Won First Debate: ETFs in Focus
Van Eck Announces Primary Listing Venue Change for Two Market Vectors� ETFs
NEW YORK--(BUSINESS WIRE)--Van Eck announced today that it plans to change the primary listing venue of its Market Vectors Biotech ETF (BBH) and Market Vectors Pharmaceutical ETF (PPH) from NYSE Arca, Inc. (“NYSE Arca”) to the NASDAQ Stock ...
This Generic Drug ETF Deserves Consideration Amid Biotech Weakness
The VanEck Vectors Generic Drugs ETF (NASDAQ:GNRX) (Expense Ratio 0.55%) debuted in January of this year, so it is still rather new to the marketplace and thus likely not well-known among investors at this point, especially judging from its low AUM of ...
Van Eck Global Announces Market Vectors Equity ETFs 2015 Distributions
Market Vectors exchange-traded products have been sponsored by Van Eck Global since 2006 when the firm launched the nation's first gold-mining ETF. Today, Market Vectors ETFs and ETNs span several asset classes, including equities, fixed income ...
Get Major Biotechs With BBH ETF (BBH)
This is due in part to the entrenched nature of many of the leading biotech firms, just as it is for the larger healthcare sector.
Illumina's Pain Infects Biotech ETFs
Though officially a medical equipment company, it is a key holding in iShares Nasdaq Biotechnology ETF (IBB) and the VanEck Vectors Biotech ETF (BBH), which fell 2.5% and 2.3% respectively. The S&P 500 and the Nasdaq are each down 0.7%. Illumina ...
Van Eck Launches Market Vectors� Generic Drugs ETF (GNRX)
NEW YORK--(BUSINESS WIRE)--Van Eck Global has launched the Market Vectors Generic Drugs ETF (NASDAQ: GNRX), the first and only Exchange-Traded Fund (ETF) to target global manufacturers of generic drugs and biosimilars, similar copies of ... Van Eck ...
Generic Drug ETF Not So Generic  Financial Advisor Magazine (registration)
Daily ETF Watch: Generic Drug Fund Debuts
Biotech ETF Industry Outlook
The biotech sector has had a rough start to the year with the NASDAQ Biotechnology Index declining approximately 16% year-to-date.
Biotech Stocks Show Signs Of Revival, But Beware Of Side Effects
Next in line are $821 million First Trust NYSE Arca Biotech ETF (FBT) and $511 million VanEck Vectors Biotech ETF (BBH). They're up roughly a respective 4% and 1% in the past three months.
Can the Biotech Sector Turn it Around Before Year-End?
From Zacks Research: The biotech sector has had a rough start to the year with the NASDAQ Biotechnology Index declining approximately 16% year-to-date.